
Bioorganic and Medicinal Chemistry Letters p. 1897 - 1902 (1998)
Update date:2022-08-04
Topics:
Yoshida, Yoshiki
Barrett, David
Azami, Hidenori
Morinaga, Chizu
Matsumoto, Yoshimi
Takasugi, Hisashi
The synthesis and in vitro optimization of the anti-Helicobacter pylori activity of a novel series of benzyloxyisoquinoline derivatives discovered by a random screening process, are described. FR180102 (7f), having a 3- acetamido-2,6-dichlorobenzyl moiety, was found to have extremely potent activity against H. pylori and no effect against a series of common Gram- positive and Gram-negative bacteria.
View MoreRongCheng K&S Chemical Co.,Ltd
Contact:0631-7336369
Address:rongcheng ,shandong province china
Chengda Pharmaceuticals Co., Ltd.
Contact:+86-573-84601188
Address:hengshan Road 5# in Jiashan, zhejiang
Nanjing distinctions Medical Technology Co., Ltd.(expird)
Contact:+86-15996203785 13914714059
Address:nanjing,jiangsu , China
website:http://www.china-sinoway.com
Contact:+86-592-5853819
Address:16/F,Huicheng Comm,Complex,No839 XiaHe Rd, Xiamen,China
Shanghai Norky Pharmaceutical Co., LTD.
website:http://www.norkypharm.com
Contact:86-21-61075300
Address:1165 Jiangning Road, Office 1502, Shanghai, China
Doi:10.1021/ic302786v
(2013)Doi:10.1016/S0968-0896(99)00215-1
(1999)Doi:10.1002/asia.201801454
(2018)Doi:10.1246/bcsj.34.1846
(1961)Doi:10.1002/jhet.5570350235
(1998)Doi:10.1134/S1070363219040169
(2019)